BAMCO Inc’s Adaptive Biotechnologies ADPT Stock Holding History

BAMCO Inc’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-352,825	Closed	-$12M	–	405
2021 Q3	$12M	Sell	352,825 -120,000	-25%	-$4.34M	0.03%	292
2021 Q2	$19.3M	Sell	472,825 -42,333	-8%	-$1.65M	0.04%	252
2021 Q1	$20.7M	Sell	515,158 -7,724	-1%	-$418K	0.05%	230
2020 Q4	$30.9M	Buy	522,882 +4,357	+0.8%	+$225K	0.08%	181
2020 Q3	$25.2M	Buy	518,525 +2,800	+0.5%	+$118K	0.08%	171
2020 Q2	$25M	Buy	515,725 +1,251	+0.2%	+$45.6K	0.09%	152
2020 Q1	$14.3M	Sell	514,474 -261,545	-34%	-$7.3M	0.07%	172
2019 Q4	$23.2M	Sell	776,019 -83,449	-10%	-$2.4M	0.09%	155
2019 Q3	$26.6M	Buy	859,468 +202,668	+31%	+$8.27M	0.11%	146
2019 Q2	$31.7M	Buy	+656,800	New	+$29.1M	0.13%	142

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BAMCO Inc's ADPT Position: Q4 2021 in Review

BAMCO Inc sold out of Adaptive Biotechnologies (ADPT) in Q4 2021, closing a stake of 352,825 shares — an estimated $12M sold.

BAMCO Inc first reported a position in ADPT in Q2 2019 and held it in 10 quarters. The position peaked at $31.7M in Q2 2019. 214 funds tracked by Wall St. Rank hold ADPT as of Q4 2021.

BAMCO Inc reported no remaining Adaptive Biotechnologies position as of Q4 2021 after selling out during the quarter.
BAMCO Inc sold 352,825 Adaptive Biotechnologies shares in Q4 2021, an estimated $12M.
BAMCO Inc first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 10 quarters.
BAMCO Inc's Adaptive Biotechnologies position peaked at $31.7M in Q2 2019.
214 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2021.

Based on BAMCO Inc's 13F filing for Q4 2021, filed 14 Feb 2022.